OFG
PBLA

Oxford Financial Group’s Panbela Therapeutics, Inc. Common Stock PBLA Stock Holding History

Oxford Financial Group’s Portfolio PBLA Stock Details PBLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1
Closed -$1.47K – 283
2022
Q4 		$1.47K Hold
1
– – ﹤0.01% 260
2022
Q3 		$5K Buy
+1
New +$21K ﹤0.01% 229

Other funds holding PBLA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

Oxford Financial Group's PBLA Position: Q1 2023 in Review

Oxford Financial Group sold out of Panbela Therapeutics, Inc. Common Stock (PBLA) in Q1 2023, closing a stake of 1 share — an estimated $1.47K sold.

Oxford Financial Group first reported a position in PBLA in Q3 2022 and held it in 2 quarters. The position peaked at $5K in Q3 2022. 15 funds tracked by Wall St. Rank hold PBLA as of Q1 2023.

  • Oxford Financial Group reported no remaining Panbela Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Oxford Financial Group sold 1 Panbela Therapeutics, Inc. Common Stock share in Q1 2023, an estimated $1.47K.
  • Oxford Financial Group first reported a position in Panbela Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Oxford Financial Group's Panbela Therapeutics, Inc. Common Stock position peaked at $5K in Q3 2022.
  • 15 funds tracked by Wall St. Rank held Panbela Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Oxford Financial Group's 13F filing for Q1 2023, filed 12 May 2023.